| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2928278 | Indian Heart Journal | 2014 | 4 Pages |
Abstract
Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively acts on Na+ channels and delays atrial depolarization, was tried successfully.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Aditi Vaishnav, Avani Vaishnav, Yash Lokhandwala,